Your session is about to expire
← Back to Search
Ancillary-Correlative (cytology specimen collection) for Ganglioneuroblastoma
N/A
Recruiting
Led By Michael Hogarty
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
Summary
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
Eligible Conditions
- Ganglioneuroblastoma
- Neuroblastoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Database of the known biologic prognostic factors for patients on therapeutic studies
Expression pattern of neurotrophin-related genes in diagnostic neuroblastoma tumors
Factors currently used for risk-group assignment (DNA content, MYCN copy number, and tumor histology)
+3 moreSecondary outcome measures
Incidence of OMA
Incidence of spinal cord compression
MYCN status per blood
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Ancillary-Correlative (cytology specimen collection)Experimental Treatment2 Interventions
Patients undergo collection of blood, tissue, and bone marrow samples for analysis via RT-PCR, quantitative PCR, flow cytometry, and FISH.
Find a Location
Who is running the clinical trial?
Children's Oncology GroupLead Sponsor
457 Previous Clinical Trials
229,830 Total Patients Enrolled
5 Trials studying Ganglioneuroblastoma
1,635 Patients Enrolled for Ganglioneuroblastoma
National Cancer Institute (NCI)NIH
13,841 Previous Clinical Trials
40,992,815 Total Patients Enrolled
11 Trials studying Ganglioneuroblastoma
2,354 Patients Enrolled for Ganglioneuroblastoma
Michael HogartyPrincipal InvestigatorChildren's Oncology Group
Share this study with friends
Copy Link
Messenger